Learning Objectives:

1. Recognize that changes in epidemiology of myocarditis over the past century as the impact on the apparent clinical spectrum of disease.

2. Describe the clinical, imaging and histologic predictors of death, ventricular arrhythmia and heart transplantation in acute myocarditis.

3. Differentiate the treatment of lymphocytic myocarditis from giant cell myocarditis, immune checkpoint inhibitor myocarditis, and cardiac sarcoidosis.

Session date: 
02/17/2023 - 12:00pm to 1:00pm CST
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Leslie T. Cooper, Jr., M.D.